WO2022100195A1 - Method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride - Google Patents

Method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride Download PDF

Info

Publication number
WO2022100195A1
WO2022100195A1 PCT/CN2021/114067 CN2021114067W WO2022100195A1 WO 2022100195 A1 WO2022100195 A1 WO 2022100195A1 CN 2021114067 W CN2021114067 W CN 2021114067W WO 2022100195 A1 WO2022100195 A1 WO 2022100195A1
Authority
WO
WIPO (PCT)
Prior art keywords
fluoro
metal
chloride
methoxybenzenesulfonyl chloride
lithium
Prior art date
Application number
PCT/CN2021/114067
Other languages
French (fr)
Chinese (zh)
Inventor
张澎涛
徐俊杰
竺伟
Original Assignee
尚科生物医药(上海)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 尚科生物医药(上海)有限公司 filed Critical 尚科生物医药(上海)有限公司
Publication of WO2022100195A1 publication Critical patent/WO2022100195A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/78Halides of sulfonic acids
    • C07C309/86Halides of sulfonic acids having halosulfonyl groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/87Halides of sulfonic acids having halosulfonyl groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton

Definitions

  • the present disclosure belongs to the field of medicinal chemistry, and in particular relates to a method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride.
  • 2-Fluoro-5-methoxybenzenesulfonyl chloride (CAS number: 1214334-01-6), whose structure is shown in formula I, is an important intermediate for the synthesis of various new drugs.
  • Patent WO2014140065 discloses a new compound, N-(4-(azaindol-6-yl)-phenyl)-sulfonamide, which is a valuable pharmacologically active compound that modulates protein kinase activity, especially Serum and glucocorticoid-regulated kinase (SGK) activity is a potential drug for the treatment of diseases with inappropriate SGK activity, such as degenerative joint diseases or inflammatory processes such as osteoarthritis or rheumatism.
  • SGK Serum and glucocorticoid-regulated kinase
  • Patent WO2015198045 discloses new compounds, 3-substituted 2-aminoindole derivatives and analogs, which are potential drugs for the treatment or prevention of GPR43 receptor-related disorders, such as diabetes, obesity and inflammatory bowel disease.
  • 2-fluoro-5-methoxybenzenesulfonyl chloride is an important raw material for the synthesis of related compounds, and the synthetic route is shown in Scheme 1.
  • the purpose of the present disclosure is to provide a preparation method of 2-fluoro-5-methoxybenzenesulfonyl chloride which is easy to operate and easy to industrialize in view of the deficiencies of the prior art.
  • X is selected from F, Cl, Br and I; M is selected from Mg, Zn, Li and combinations thereof.
  • the operation steps are: using 3-bromo-4-fluoroanisole as raw material, reacting with metal or metal reagent to obtain aryl metal reagent III, and then reacting with sulfonyl chloride to obtain 2-fluoro-5-methoxyl group Benzenesulfonyl chloride.
  • the metal or metal reagent is selected from the group consisting of C 1 -C 6 straight or branched alkyl magnesium, C 1 -C 6 straight or branched alkyl magnesium halide, lithium halide, C 1 -C 6 One or a mixture of linear or branched alkyl lithium, metal magnesium, metal zinc, and metal lithium.
  • the metal or metal reagent is selected from magnesium metal, C1 - C6 straight or branched alkyl magnesium, C1 - C6 straight or branched alkyl magnesium halide lithium halide.
  • the metal reagent is selected from the group consisting of isopropylmagnesium chloride lithium chloride, isopropylmagnesium bromide lithium chloride, isopropylmagnesium chloride, isopropylmagnesium bromide, preferably isopropylmagnesium chloride lithium chloride .
  • the beneficial effect of the present disclosure is that the present disclosure provides a new and unreported preparation method of 2-fluoro-5-methoxybenzenesulfonyl chloride, using 3-bromo-4-fluoroanisole as a raw material,
  • the reaction steps are short, the operation is simple, the reaction conditions are mild, and the method is suitable for industrial production.
  • the tetrahydrofuran was removed by rotary evaporation, extracted with dichloromethane, washed with water, and rotary evaporation was performed to obtain a brown liquid, and oil pump distillation was used to obtain 4.2 g of a colorless liquid.
  • the 1 H NMR chart is shown in FIG. 1 .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present disclosure provides a method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride. 3-bromo-4-fluoroanisole is used as a raw material and reacts with a metal or metal reagent to obtain an aryl metal reagent, which then reacts with sulfonyl chloride to obtain 2-fluoro-5-methoxybenzenesulfonyl chloride. The method provided by the present disclosure has short reaction steps, simple operation and mild reaction conditions, and is suitable for industrial production.

Description

一种制备2-氟-5-甲氧基苯磺酰氯的方法A kind of method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride
相关申请的交叉引用CROSS-REFERENCE TO RELATED APPLICATIONS
本公开要求于2020年11月16日提交中国专利局的申请号为202011278152.X、名称为“一种制备2-氟-5-甲氧基苯磺酰氯的方法”的中国专利申请的优先权,其全部内容通过引用结合在本公开中。This disclosure claims the priority of the Chinese patent application entitled "A Method for Preparing 2-Fluoro-5-Methoxybenzenesulfonyl Chloride" with application number 202011278152.X filed with the China Patent Office on November 16, 2020 , the entire contents of which are incorporated by reference in this disclosure.
技术领域technical field
本公开属于药物化学领域,具体涉及一种制备2-氟-5-甲氧基苯磺酰氯的方法。The present disclosure belongs to the field of medicinal chemistry, and in particular relates to a method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride.
背景技术Background technique
2-氟-5-甲氧基苯磺酰氯(CAS号:1214334-01-6),结构如式I所示,是合成多种新药的重要中间体。2-Fluoro-5-methoxybenzenesulfonyl chloride (CAS number: 1214334-01-6), whose structure is shown in formula I, is an important intermediate for the synthesis of various new drugs.
Figure PCTCN2021114067-appb-000001
Figure PCTCN2021114067-appb-000001
专利WO2014140065中公开一种新的化合物,N-(4-(氮杂吲哚-6-基)-苯基)-磺酰胺是有价值的药理学活性的化合物,其调节蛋白激酶活性,特别是血清和糖皮质激素调节激酶(SGK)的活性,是潜在的用于治疗SGK活性不适当疾病的药物,例如退化性关节疾病或炎性过程诸如骨关节炎或风湿病。其中,N-[4-(3-氨基-4-异丁氧基-1H-吡唑并[3,4-d]嘧啶-6-基)-苯基]-2-氟-5-甲氧基-苯磺酰胺;N-[4-(3-氨基-1H-吡唑并[3,4-d]嘧啶-6-基)-苯基]-2-氟-5-甲氧基-苯磺酰胺;N-{4-[4-(1-乙酰基-哌啶-4-基氧基)-3-甲基-1H-吡唑并[3,4-d]嘧啶-6-基]-苯基}-2-氟-5-甲氧基-苯磺酰胺等都是由2-氟-5-甲氧基苯磺酰氯作为原料制备而来。Patent WO2014140065 discloses a new compound, N-(4-(azaindol-6-yl)-phenyl)-sulfonamide, which is a valuable pharmacologically active compound that modulates protein kinase activity, especially Serum and glucocorticoid-regulated kinase (SGK) activity is a potential drug for the treatment of diseases with inappropriate SGK activity, such as degenerative joint diseases or inflammatory processes such as osteoarthritis or rheumatism. Wherein, N-[4-(3-amino-4-isobutoxy-1H-pyrazolo[3,4-d]pyrimidin-6-yl)-phenyl]-2-fluoro-5-methoxy yl-benzenesulfonamide; N-[4-(3-Amino-1H-pyrazolo[3,4-d]pyrimidin-6-yl)-phenyl]-2-fluoro-5-methoxy-benzene Sulfonamide; N-{4-[4-(1-Acetyl-piperidin-4-yloxy)-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl] -Phenyl}-2-fluoro-5-methoxy-benzenesulfonamide, etc. are all prepared from 2-fluoro-5-methoxybenzenesulfonyl chloride as a raw material.
专利WO2015198045中公开新化合物3-取代的2-胺基吲哚衍生物及类似物,其是潜在的治疗或预防与GPR43受体有关病症的药物,如糖尿病、肥胖症和炎症性肠病。其中,2-氟-5-甲氧基苯磺酰氯是合成相关化合物的重要原料,合成路线如Scheme 1所示。Patent WO2015198045 discloses new compounds, 3-substituted 2-aminoindole derivatives and analogs, which are potential drugs for the treatment or prevention of GPR43 receptor-related disorders, such as diabetes, obesity and inflammatory bowel disease. Among them, 2-fluoro-5-methoxybenzenesulfonyl chloride is an important raw material for the synthesis of related compounds, and the synthetic route is shown in Scheme 1.
Figure PCTCN2021114067-appb-000002
Figure PCTCN2021114067-appb-000002
目前,并无现有技术公开报道2-氟-5-甲氧基苯磺酰氯的制备方法。At present, there is no prior art publicly reporting the preparation method of 2-fluoro-5-methoxybenzenesulfonyl chloride.
发明内容SUMMARY OF THE INVENTION
本公开的目的在于针对现有技术的不足,提供一种操作简单易于产业化的2-氟-5-甲氧基苯磺酰氯的制备方法。The purpose of the present disclosure is to provide a preparation method of 2-fluoro-5-methoxybenzenesulfonyl chloride which is easy to operate and easy to industrialize in view of the deficiencies of the prior art.
本公开采用的技术方案如下:The technical scheme adopted in the present disclosure is as follows:
Figure PCTCN2021114067-appb-000003
Figure PCTCN2021114067-appb-000003
其中,X选自F、Cl、Br和I;M选自Mg、Zn、Li及其组合。Wherein, X is selected from F, Cl, Br and I; M is selected from Mg, Zn, Li and combinations thereof.
操作步骤为:以3-溴-4-氟苯甲醚为原料,经与金属或金属试剂发生反应制得芳基金属试剂III,再与磺酰氯反应制得2-氟-5-甲氧基苯磺酰氯。The operation steps are: using 3-bromo-4-fluoroanisole as raw material, reacting with metal or metal reagent to obtain aryl metal reagent III, and then reacting with sulfonyl chloride to obtain 2-fluoro-5-methoxyl group Benzenesulfonyl chloride.
在一些实施方式中,所述金属或金属试剂选自C 1-C 6直链或支链烷基镁、C 1-C 6直链或支链烷基卤化镁卤化锂、C 1-C 6直链或支链烷基锂、金属镁、金属 锌、金属锂中的一种或几种的混合物。 In some embodiments, the metal or metal reagent is selected from the group consisting of C 1 -C 6 straight or branched alkyl magnesium, C 1 -C 6 straight or branched alkyl magnesium halide, lithium halide, C 1 -C 6 One or a mixture of linear or branched alkyl lithium, metal magnesium, metal zinc, and metal lithium.
在一些实施方式中,所述金属或金属试剂选自金属镁、C 1-C 6直链或支链烷基镁、C 1-C 6直链或支链烷基卤化镁卤化锂。 In some embodiments, the metal or metal reagent is selected from magnesium metal, C1 - C6 straight or branched alkyl magnesium, C1 - C6 straight or branched alkyl magnesium halide lithium halide.
在一些实施方式中,所述金属试剂选自异丙基氯化镁氯化锂、异丙基溴化镁氯化锂、异丙基氯化镁、异丙基溴化镁,优选异丙基氯化镁氯化锂。In some embodiments, the metal reagent is selected from the group consisting of isopropylmagnesium chloride lithium chloride, isopropylmagnesium bromide lithium chloride, isopropylmagnesium chloride, isopropylmagnesium bromide, preferably isopropylmagnesium chloride lithium chloride .
本公开的有益效果在于,本公开提供了一种新的未见报道过的2-氟-5-甲氧基苯磺酰氯的制备方法,选用3-溴-4-氟苯甲醚为原料,反应步骤简短,操作简单,反应条件温和,适合于工业化生产。The beneficial effect of the present disclosure is that the present disclosure provides a new and unreported preparation method of 2-fluoro-5-methoxybenzenesulfonyl chloride, using 3-bromo-4-fluoroanisole as a raw material, The reaction steps are short, the operation is simple, the reaction conditions are mild, and the method is suitable for industrial production.
附图说明Description of drawings
图1实施例1中2-氟-5-甲氧基苯磺酰氯的 1HNMR图 Figure 11 HNMR chart of 2-fluoro-5-methoxybenzenesulfonyl chloride in Example 1
具体实施方式Detailed ways
下面结合实施例对本公开的技术内容作进一步的阐述,其目的是为了更好的理解本公开的内容,但本公开的保护范围不限于此。The technical content of the present disclosure will be further elaborated below in conjunction with the embodiments, the purpose of which is to better understand the content of the present disclosure, but the protection scope of the present disclosure is not limited thereto.
实施例1 2-氟-5-甲氧基苯磺酰氯的制备Example 1 Preparation of 2-fluoro-5-methoxybenzenesulfonyl chloride
将35mL异丙基氯化镁氯化锂加入50mL三颈瓶中,0℃下,加入6.0g 3-溴-4-氟苯甲醚搅拌反应1小时。将反应液降温至-30℃,并向其中加入溶于四氢呋喃中的磺酰氯,继续反应0.5小时,反应结束后,加水淬灭,继续搅拌0.5小 时。旋转蒸掉四氢呋喃,用二氯甲烷萃取,水洗,旋转蒸发得到棕色液体,油泵蒸馏得到无色液体4.2g。 1HNMR图见图1。 35 mL of isopropylmagnesium chloride and lithium chloride were added to a 50 mL three-neck flask, and at 0° C., 6.0 g of 3-bromo-4-fluoroanisole was added and the reaction was stirred for 1 hour. The reaction solution was cooled to -30°C, sulfonyl chloride dissolved in tetrahydrofuran was added thereto, and the reaction was continued for 0.5 hour. After the reaction was completed, water was added to quench, and stirring was continued for 0.5 hour. The tetrahydrofuran was removed by rotary evaporation, extracted with dichloromethane, washed with water, and rotary evaporation was performed to obtain a brown liquid, and oil pump distillation was used to obtain 4.2 g of a colorless liquid. The 1 H NMR chart is shown in FIG. 1 .
实施例2 2-氟-5-甲氧基苯磺酰氯的制备Example 2 Preparation of 2-fluoro-5-methoxybenzenesulfonyl chloride
将200mL异丙基溴化镁加入500mL三颈瓶中,0℃下,加入60g 3-溴-4-氟苯甲醚搅拌反应1小时。将反应液降温至-30℃,并向其中加入溶于四氢呋喃中的磺酰氯,继续反应0.5小时,反应结束后,加水淬灭,继续搅拌1小时。旋转蒸掉四氢呋喃,用二氯甲烷萃取,水洗,旋转蒸发得到棕色液体,油泵蒸馏得到无色液体38.1g。200 mL of isopropylmagnesium bromide was added to a 500 mL three-neck flask, and 60 g of 3-bromo-4-fluoroanisole was added at 0° C. to stir the reaction for 1 hour. The reaction solution was cooled to -30°C, and sulfonyl chloride dissolved in tetrahydrofuran was added thereto, and the reaction was continued for 0.5 hour. After the reaction was completed, water was added to quench, and stirring was continued for 1 hour. The tetrahydrofuran was removed by rotary evaporation, extracted with dichloromethane, washed with water, and rotary evaporated to obtain a brown liquid, and oil pump distillation to obtain 38.1 g of a colorless liquid.
实施例3 2-氟-5-甲氧基苯磺酰氯的制备Example 3 Preparation of 2-fluoro-5-methoxybenzenesulfonyl chloride
将3g金属锂加入500mL三颈瓶中,0℃下,加入5g 3-溴-4-氟苯甲醚搅拌反应4小时。将反应液降温至-45℃,并向其中加入溶于四氢呋喃中的磺酰氯,继续反应2小时,反应结束后,加水淬灭,继续搅拌1小时。旋转蒸掉四氢呋喃,用二氯甲烷萃取,水洗,旋转蒸发得到棕色液体,油泵蒸馏得到无色液体2.3g。3 g of metallic lithium was added to a 500 mL three-neck flask, and 5 g of 3-bromo-4-fluoroanisole was added at 0°C to stir the reaction for 4 hours. The reaction solution was cooled to -45°C, and sulfonyl chloride dissolved in tetrahydrofuran was added thereto, and the reaction was continued for 2 hours. After the reaction was completed, water was added to quench, and stirring was continued for 1 hour. The tetrahydrofuran was removed by rotary evaporation, extracted with dichloromethane, washed with water, and rotary evaporation was performed to obtain a brown liquid, and oil pump distillation was used to obtain 2.3 g of a colorless liquid.
实施例4 2-氟-5-甲氧基苯磺酰氯的制备Example 4 Preparation of 2-fluoro-5-methoxybenzenesulfonyl chloride
将2g金属锌加入500mL三颈瓶中,0℃下,加入5g 3-溴-4-氟苯甲醚搅拌反应3小时。将反应液降温至-40℃,并向其中加入溶于四氢呋喃中的磺酰氯,继续反应1小时,反应结束后,加水淬灭,继续搅拌1小时。旋转蒸掉四氢呋喃,用二氯甲烷萃取,水洗,旋转蒸发得到棕色液体,油泵蒸馏得到无色液体 1.7g。2g of metallic zinc was added to a 500mL three-neck flask, and at 0°C, 5g of 3-bromo-4-fluoroanisole was added and the reaction was stirred for 3 hours. The reaction solution was cooled to -40°C, and sulfonyl chloride dissolved in tetrahydrofuran was added thereto, and the reaction was continued for 1 hour. After the reaction was completed, water was added to quench, and stirring was continued for 1 hour. The tetrahydrofuran was removed by rotary evaporation, extracted with dichloromethane, washed with water, and rotary evaporation was performed to obtain a brown liquid, and oil pump distillation was used to obtain 1.7 g of a colorless liquid.

Claims (2)

  1. 一种制备2-氟-5-甲氧基苯磺酰氯的方法,其特征在于,以3-溴-4-氟苯甲醚为原料,与金属或金属试剂发生反应制得芳基金属试剂III,再与磺酰氯反应制得2-氟-5-甲氧基苯磺酰氯;A method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride, characterized in that, using 3-bromo-4-fluoroanisole as a raw material, reacting with metal or metal reagent to obtain aryl metal reagent III , and then react with sulfonyl chloride to obtain 2-fluoro-5-methoxybenzenesulfonyl chloride;
    具体路线如下:The specific route is as follows:
    Figure PCTCN2021114067-appb-100001
    Figure PCTCN2021114067-appb-100001
    其中,X选自F、Cl、Br和I;M选自Mg、Zn、Li及其组合。Wherein, X is selected from F, Cl, Br and I; M is selected from Mg, Zn, Li and combinations thereof.
  2. 一种如权利要求1所述的制备方法,其特征在于,所述金属或金属试剂选自C 1-C 6直链或支链烷基镁、C 1-C 6直链或支链烷基卤化镁卤化锂、C 1-C 6直链或支链烷基锂、金属镁、金属锌、金属锂中的一种或几种的混合物。 A preparation method as claimed in claim 1, characterized in that, the metal or metal reagent is selected from C 1 -C 6 straight-chain or branched alkyl magnesium, C 1 -C 6 straight-chain or branched alkyl One or more mixtures of magnesium halide lithium halide, C 1 -C 6 linear or branched alkyl lithium, metal magnesium, metal zinc, and metal lithium.
PCT/CN2021/114067 2020-11-16 2021-08-23 Method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride WO2022100195A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202011278152.XA CN114507163A (en) 2020-11-16 2020-11-16 Method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride
CN202011278152.X 2020-11-16

Publications (1)

Publication Number Publication Date
WO2022100195A1 true WO2022100195A1 (en) 2022-05-19

Family

ID=81546439

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/114067 WO2022100195A1 (en) 2020-11-16 2021-08-23 Method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride

Country Status (2)

Country Link
CN (1) CN114507163A (en)
WO (1) WO2022100195A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103012407A (en) * 2011-09-27 2013-04-03 赛诺菲 N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides and application of N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides as medicines
CN108003161A (en) * 2016-10-28 2018-05-08 正大天晴药业集团股份有限公司 Neurotrophic factor tyrosine kinase receptor inhibitor
CN109593803A (en) * 2018-12-24 2019-04-09 上海健康医学院 (R) preparation method of -2- (2,5- difluorophenyl) pyrrolidines or its salt
CN109593802A (en) * 2018-12-24 2019-04-09 上海健康医学院 The preparation method of one kind (R) -2- (2,5- difluorophenyl) pyrrolidines or its salt
WO2020079205A1 (en) * 2018-10-19 2020-04-23 Les Laboratoires Servier New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
CN111647011A (en) * 2020-07-16 2020-09-11 宁夏中星显示材料有限公司 Preparation method of monohalogenated phenylboronic acid

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103012407A (en) * 2011-09-27 2013-04-03 赛诺菲 N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides and application of N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides as medicines
CN108003161A (en) * 2016-10-28 2018-05-08 正大天晴药业集团股份有限公司 Neurotrophic factor tyrosine kinase receptor inhibitor
WO2020079205A1 (en) * 2018-10-19 2020-04-23 Les Laboratoires Servier New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
CN109593803A (en) * 2018-12-24 2019-04-09 上海健康医学院 (R) preparation method of -2- (2,5- difluorophenyl) pyrrolidines or its salt
CN109593802A (en) * 2018-12-24 2019-04-09 上海健康医学院 The preparation method of one kind (R) -2- (2,5- difluorophenyl) pyrrolidines or its salt
CN111647011A (en) * 2020-07-16 2020-09-11 宁夏中星显示材料有限公司 Preparation method of monohalogenated phenylboronic acid

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BHATTACHARYA S. N., EABORN C., WALTON D. R. M.: "Preparation of arenesulphonyl chlorides from Grignard reagents", JOURNAL OF THE CHEMICAL SOCIETY, SECTION C: ORGANIC CHEMISTRY.>6015C, CHEMICAL SOCIETY. LETCHWORTH., GB, 1 January 1968 (1968-01-01), GB , pages 1265, XP055930352, ISSN: 0022-4952, DOI: 10.1039/j39680001265 *
DAVIES ALYN T., CURTO JOHN M., BAGLEY SCOTT W., WILLIS MICHAEL C.: "One-pot palladium-catalyzed synthesis of sulfonyl fluorides from aryl bromides", CHEMICAL SCIENCE, ROYAL SOCIETY OF CHEMISTRY, UNITED KINGDOM, vol. 8, no. 2, 1 January 2017 (2017-01-01), United Kingdom , pages 1233 - 1237, XP055930360, ISSN: 2041-6520, DOI: 10.1039/C6SC03924C *
HAY J. V.: "CHEMISTRY OF SULFONYLUREA HERBICIDES.", PESTICIDE SCIENCE., ELSEVIER APPLIED SCIENCE PUBLISHER. BARKING., GB, vol. 29., no. 03., 1 January 1990 (1990-01-01), GB , pages 247 - 261., XP000202810, ISSN: 0031-613X *
LEO A. PAQUETTE: "Encyclopedia of reagents for organic synthesis; Vol. 7 : Sod - Trim", WILEY , Chichester , ISBN: 978-0-470-84289-8, article ANILKUMAR R., BURTON DONALD J.: "Chloropentafluorobenzene", XP055930355, DOI: 10.1002/047084289X.rn00539 *
MICHAEL A. WALLACE, CONRAD E. RAAB, DENNIS C. DEAN, DAVID G. MELILLO: "Synthesis of [35S]aryl sulfonyl chlorides from [35S]elemental sulfur", JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, JOHN WILEY & SONS LTD., GB, vol. 48, no. 4, 30 March 2005 (2005-03-30), GB , pages 275 - 283, XP055661462, ISSN: 0362-4803, DOI: 10.1002/jlcr.920 *
ZEKRI NEGAR; FAREGHI-ALAMDARI REZA; MOMENI-FARD BEHNAZ: "Synthesis of ketamine from a nontoxic procedure: a new and efficient route", JOURNAL OF CHEMICAL SCIENCES, SPRINGER INDIA, NEW DELHI, vol. 132, no. 1, 25 September 2020 (2020-09-25), New Delhi, XP037255628, ISSN: 0974-3626, DOI: 10.1007/s12039-020-01827-9 *

Also Published As

Publication number Publication date
CN114507163A (en) 2022-05-17

Similar Documents

Publication Publication Date Title
EP0570594B1 (en) Hydroxamic acid derivative based on aromatic sulfonamide
CA3082115A1 (en) Process for preparing tapinarof
JPH03128343A (en) Novel zinc derivative of anti-inflammatory drug having improved therapeutic characteristics
US3987091A (en) 11,12-secoprostaglandins
US3853952A (en) 2-ethynylcyclopropane compounds and process for the preparation thereof
US3120551A (en) 5-(4-biphenylyl)-3-methylvaleric acid and functional derivatives thereof
US4159279A (en) Nuclear substituted 2-hydroxyphenylmethanesulfamic acids
EP0000200B1 (en) New n-amidino-3,5-diamino-6-substituted-2-pyrazinecarboxamides and process for preparing same
WO2022100195A1 (en) Method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride
Fieser et al. The Addition of Dichlorocarbene to cis, cis-1, 5-Cyclooctadiene
US4091107A (en) 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins
US3873539A (en) Substituted-4-aminoacetyl alkanoylphenones
JPS62123180A (en) P-aminophenol derivative
Henry The Reaction of Amines with N-Methyl-N-nitroso-N'-nitroguanidine
JPH0567142B2 (en)
IE45110B1 (en) New phenethylamine derivatives and salts thereof,as well as processes for their preparation and pharmaceutical compositions incorporating them
FI70711C (en) PHARMACEUTICAL FORM OF PHARMACOLOGICAL ACTIVE HOEGERVIDIDES ISOMER AV (+) - OZOLINONESTER
US4273787A (en) 1-Alkyl,1-phenyl-butenes
US4034045A (en) 2,4-Disubstituted-4b,5,6,7,8,8a,9,10-octahydro-9-oxo-phenanthrenes
US3598861A (en) 2-(5'-phenyl-m-terphenyl - 4 - yloxy) lower aliphatic monocarbocyclic acids and esters thereof
EP0013726B1 (en) Indanyloxamic derivatives, their preparation and pharmaceutical compositions containing them
JPS5857419B2 (en) Method for producing 1-cyclopropyl-1-phenyl-ω-amino-1-lower alkanoyloxyalkanes
US4049825A (en) Aminoalkylethers; composition and method of use
JPS5919537B2 (en) Oxindole derivative
US2293877A (en) Amino compound

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21890724

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21890724

Country of ref document: EP

Kind code of ref document: A1